Sumitomo Mitsui Trust Group
NVAX icon

Sumitomo Mitsui Trust Group’s Novavax NVAX Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,365
Closed -$224K – 1232
2022
Q2 		$224K Sell
4,365
-173,986
-98% -$9.01M ﹤0.01% 1197
2022
Q1 		$13.1M Buy
178,351
+3,814
+2% +$340K 0.01% 773
2021
Q4 		$25M Sell
174,537
-6,214
-3% -$1.07M 0.02% 686
2021
Q3 		$37.5M Sell
180,751
-7,727
-4% -$1.7M 0.02% 613
2021
Q2 		$40M Buy
+188,478
New +$34.5M 0.02% 608

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sumitomo Mitsui Trust Group's NVAX Position: Q3 2022 in Review

Sumitomo Mitsui Trust Group sold out of Novavax (NVAX) in Q3 2022, closing a stake of 4,365 shares — an estimated $224K sold.

Sumitomo Mitsui Trust Group first reported a position in NVAX in Q2 2021 and held it in 5 quarters. The position peaked at $40M in Q2 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • Sumitomo Mitsui Trust Group reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 4,365 Novavax shares in Q3 2022, an estimated $224K.
  • Sumitomo Mitsui Trust Group first reported a position in Novavax in Q2 2021 and held it in 5 quarters.
  • Sumitomo Mitsui Trust Group's Novavax position peaked at $40M in Q2 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2022, filed 21 Oct 2022.